Fluvoxamine and Protein C: Interaction Details
- Fluvoxamine
- LuvoxLuvox CR
- Protein C
- Ceprotin
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fluvoxamine and Protein C interaction:
Fluvoxamine
- Luvox
- Luvox CR
Protein C
- Ceprotin
We don't have a separate drug information page for Protein C. The FDA's drug directory lists it as part of Balfaxar (coagulation factor ix human, prothrombin, coagulation factor vii human, coagulation factor x human, protein c and protein s human). Have a question about Protein C? Ask a pharmacist, free →
What Happens When You Take Fluvoxamine With Protein C
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
release , and this release helps maintain hemostasis. Case-control and cohort studies have linked the combined use of and to a higher risk of bleeding.125
The reported bleeding events included epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages. When SSRIs were given together with warfarin, changes in anticoagulant effect (including more bleeding) were reported.
In patients who took warfarin and fluvoxaMINE together for 2 weeks, plasma warfarin concentrations rose by 98% and prothrombin times were prolonged. FluvoxaMINE seems to inhibit multiple isoenzymes, possibly including and , the isozymes that metabolize warfarin.35
The Fluvoxamine and Protein C Interaction, Explained
Taking fluvoxamine with Protein C (Ceprotin) may raise your chance of bleeding. Fluvoxamine can make less able to help blood clot, and Protein C is a clotting-pathway drug, so the effects can add together. You might notice nosebleeds, easy bruising, tiny red spots on the skin, or, rarely, serious bleeding. This can show up after some time rather than right away.
Do not stop or change either medicine on your own. Tell your pharmacist or doctor you take both, and report any unusual bleeding or bruising quickly. Your care team can manage this by watching you closely and adjusting your treatment if needed.
Interaction: impairment of hemostasis (increased bleeding risk). Evidence rated probable; severity major; onset delayed.
- Mechanism: deplete and impair platelet aggregation (PD). Combined with an -pathway agent, bleeding risk rises. Observational data link plus anticoagulant use to epistaxis, ecchymosis, hematoma, petechiae, and serious .
- Related data: with warfarin, fluvoxamine (/ ) raised warfarin concentrations by 98% and prolonged PT. This PK effect is specific to warfarin and is not documented for protein C concentrate.
- Management: monitor for bleeding when coadministered; for anticoagulants, periodically reassess PT/ and adjust the anticoagulant dose accordingly, with closer monitoring when fluvoxamine is started or stopped.
See the 5 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fluvoxamine and Protein C Interact
The likely mechanism
effects on hemostasis
How to Manage the Fluvoxamine and Protein C Interaction
Your care team can manage this combination, usually by watching for bleeding and tailoring doses.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely, especially when fluvoxamine is started or stopped. If you also take an such as warfarin, blood tests like PT/ may be checked periodically and the dose may need to be adjusted and individualized.
- Report nosebleeds, unusual bruising, red spots on the skin, blood in urine or stool, or any bleeding that is hard to stop.
- Tell every prescriber and pharmacist about all your medicines.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fluvoxamine or Protein C need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment
A retrospective cohort study (n=234) found a higher risk of clinically relevant bleeding (defined as hospital admission due to bleeding) in patients taking warfarin for atrial fibrillation who were receiving an at the same time or within 2 weeks after stopping it. Patients with a mean age of 72 +/- 7 years who received warfarin plus an SSRI (n=117) were matched with randomly selected patients who received warfarin alone (n=117).
The were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, 9 patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleeding episodes over 586.4 treatment years.
The total bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. Compared with warfarin alone, the hazard ratio for first bleeding during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009).
Sertraline or citalopram were the SSRIs involved in patients who bled during . Adding an SSRI was not linked to a change in warfarin dose or (p=0.48 and p=0.31, respectively). The findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, , and other than warfarin.2
-
Report 2 · Study title
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins
A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) who were also taking selective reuptake () showed a higher risk of hospitalization for non-gastrointestinal bleeding. Using national pharmacy and hospitalization records, researchers in the Netherlands identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking coumarins.
The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5), whereas the rate of bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly.3
-
Report 3 · Study title
Interaction of fluvoxamine with warfarin in an elderly woman
An 80-year-old woman in hospital was started on intravenous heparin and oral warfarin for an embolic stroke secondary to atrial fibrillation and mitral stenosis. Her warfarin dose was kept at 1 mg daily, with between 2.5 and 3.
FluvoxaMINE 25 mg daily was begun for depression, and 3 days later her warfarin dose was raised to 1.5 mg daily because of worsening left hemiparesis. Three days after that, her INR was 9.96, and a repeat INR to exclude laboratory error was 11.3.
Warfarin and fluvoxaMINE were discontinued, and fresh frozen plasma was given. Six days later warfarin was restarted at 1 mg daily, and over 4 days the INR rose to 11.8.
The elevated INR was attributed to the persisting effect of fluvoxaMINE. She was eventually stabilized on warfarin 1 mg daily with INR values between 2 and 2.5.4
-
Report 4 · Study title
Prescribing information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets
When fluvoxaMINE maleate (50 mg thrice daily) was given together with warfarin for two weeks, warfarin rose by 98% and prothrombin times were prolonged.1
Fluvoxamine and Protein C: Common Questions
How serious is the Fluvoxamine and Protein C interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fluvoxamine and Protein C interaction managed?
Your care team can manage this combination, usually by watching for bleeding and tailoring doses. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely, especially when fluvoxamine is started or stopped. If you also take an such as warfarin, blood tests like PT/ may be checked periodically and the dose may need… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fluvoxamine and Protein C Interaction
Ask in your own words about taking Fluvoxamine and Protein C together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (5)
- Product Information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets. ANI Pharmaceuticals Inc (per FDA), Baudette, MN, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. PubMed
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Yap KB & Low ST: Interaction of fluvoxamine with warfarin in an elderly woman. Singapore Med J 1999; 40:480-482.
- Product Information: LUVOX(R) CR extended-release oral capsules, fluvoxamine maleate extended-release oral capsules. Jazz Pharmaceuticals,Inc, Palo Alto, CA, 2008. DailyMed
Other Serious Interactions of Fluvoxamine and Protein C
Also serious with Fluvoxamine
- ColchicineContraindicated
- Linezolid InjectionContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
Also serious with Protein C
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fluvoxamine
- Activated CharcoalMajor
- LithiumMajor
- CaffeineModerate
- Green TeaModerate
- Black PepperModerate
- GrapeModerate
- GinkgoModerate
- MelatoninModerate
- + 187 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.